4Filing Date: Aug 3, 2026
Boston Scientific (BSX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-006882
Total Value$227.4K
Trades1
Insiders1
Transaction Details
LUDWIG EDWARD J
Director·Direct
Buy · Acquire
Common Stock
Shares+5.00K
Price$45.48
Total Value$227.4K
Shares Owned After30.36K
Transaction DateJul 31, 2026
Post-Transaction Holdings
LUDWIG EDWARD J · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 30.36K | +5.00K (19.72%) |
auto_awesomeDeep Analysis
Deep Analysis
Director Edward J. Ludwig bought 5,000 shares of Boston Scientific on the open market on 2026-07-31 — an active purchase, not a passive transaction.
lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-31
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
--- Reporting Owner ---
Name: LUDWIG EDWARD J
CIK: 0001221783
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-07-31 | Code: P (Open market purchase)
Shares: +5,000 | Price: $45.48
Total Value: $227,399.50
Shares Owned After: 30,359 | Ownership: D (Direct)
--- Signature ---
/s/ /s/ Susan Thompson, Attorney-in-Fact (2026-08-03)